# Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes

> **NCT00506298** · PHASE2 · COMPLETED · sponsor: **Zalicus** · enrollment: 150 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** bezafibrate + diflunisal
- **DRUG:** bezafibrate + placebo

## Key facts

- **NCT ID:** NCT00506298
- **Lead sponsor:** Zalicus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2009-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00506298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00506298, "Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00506298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*